Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trial. [electronic resource]
Producer: 20170612Description: e463-72 p. digitalISSN:- 2352-3018
- AIDS Vaccines -- administration & dosage
- Adjuvants, Immunologic
- Administration, Intravenous
- Adolescent
- Adult
- Antiretroviral Therapy, Highly Active
- CD4 Lymphocyte Count
- CD4-Positive T-Lymphocytes -- immunology
- DNA, Viral -- blood
- Depsipeptides -- administration & dosage
- Drug Therapy, Combination
- Granulocyte-Macrophage Colony-Stimulating Factor -- administration & dosage
- HIV Infections -- drug therapy
- HIV-1 -- drug effects
- Humans
- Immunization Schedule
- Immunologic Memory
- Injections, Intradermal
- Male
- Recombinant Proteins -- administration & dosage
- Vaccination
- Viral Load
- Virus Latency
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.